FOLLOWING the lifting of Saizen
solution for injection (somatropin)
restrictions in October, the
Department of Health (DoH) is
urging patients to ensure that their
supply does not expire before the
end of their treatment period.
The DoH stopped ordering Saizen
in July this year, through the PBS
Growth Hormone Program, as the
supplier had initiated a recall of
short dated Saizen, however the
drug’s supplier worked with the
Department and TGA to manage
the situation and from 2 October
2012 the restriction was lifted.The above article was sent to subscribers in Pharmacy Daily's issue from 12 Nov 12 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 12 Nov 12
DEMENTIA Australia has appointed comedian Geraldine Hickey (pictured) as its newest Ambassador, coinciding with the Melbourne Memory Walk & Jog event taking place this Sun.
NEW research from the Monash Addiction Research Centre has highlighted a critical shortfall in the availability of Naloxone, a life-saving medication that reverses opioid overdoses, across community pharmacies in Australia’s most populous states.
THE Senate’s Community Affairs Legislation Committee is holding a two-day inquiry into the Therapeutic Goods and Other Legislation Amendment (Vaping Reforms) Bill 2024, which is currently under discussion in Federal Parliament.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.